A Randomized, Double-blind, Active Drug Controlled, Multi-Center, Phase I/III Clinical Trial to Evaluate the Efficacy and Safety of CORETOX® in Treatment of Post Stroke Upper Limb Spasticity
Latest Information Update: 08 Dec 2021
At a glance
- Drugs Protein-free-botulinum-toxin-A-Medytox (Primary) ; Botulinum-Toxin-A
- Indications Muscle spasticity
- Focus Therapeutic Use
- Sponsors Medytox
- 01 Sep 2020 Primary endpoint (MAS(Modified Ashworth Scale)of wrist flexor) has been met as per results published in the Archives of Physical Medicine and Rehabilitation
- 01 Sep 2020 Results published in the Archives of Physical Medicine and Rehabilitation
- 25 Mar 2019 Status changed from recruiting to completed.